Treatment Side Effects
33
11
12
7
Key Insights
Highlights
Success Rate
64% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
12.1%
4 terminated out of 33 trials
63.6%
-23.0% vs benchmark
6%
2 trials in Phase 3/4
0%
0 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 7 completed trials
Clinical Trials (33)
A Randomized Study Comparing of Three Doses Nebulized Fentanyl in Older Adults
A Clinical Study on TIL for the Treatment of Advanced Solid Tumors
A Study of GC203 TIL in PDCA (RJ)
Toxicity of Treatments for Non-tuberculous Mycobacterial Infections in Cancer Patients or Not
Surgical Approach to Uterine Septum
Trazodone vs. Quetiapine for the Treatment of ICU Delirium
RCT: Trazodone vs Quetiapine vs Placebo for Treating ICU Delirium (TraQ)
Therapeutic Effect of New Biologics in Crohn's Disease
A Study of TIL in Advanced Solid Tumors (DFGD)
A Study of GC101 TIL in Advanced Breast Cancer (10hospital)
A Study of GC201 TIL in Advanced Gynecologic Tumors (10hospital)
A Study of GC101 TIL in Advanced Melanoma (10hospital)
A Study of GC101 TIL in Advanced Hepatobiliary-Pancreatic Cancers (10hospital)
A Study of GC203 TIL in Advanced Gynecologic Tumors (10hospital)
NutriCare Plus a Medically Tailored Meal Intervention Among Patients With Lung Cancer
Body Composition and Psychosocial Factors in ICI-Treated Cancer Patients
Orem's Self-Care Deficit Theory Based Nursing Interventions for Immunotherapy Treated Cancer Patients
Liver Safety Assessment During Ulipristal Acetate Treatment for Uterine Fibroids (LISA)
PACED-digitized Support During Adjuvant Endocrine Therapy
NT-proBNP to Assess Trastuzumab-induced Cardiotoxicity